Market Share of Global Autism Spectrum Disorders Treatment Industry
The autism spectrum disorders treatment market is competitive and nearly consolidated with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are PaxMedica, Yamo Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, and Q BioMed Inc., among other players.
Autism Spectrum Disorders Treatment Market Leaders
PaxMedica
Yamo Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd.
F. Hoffmann-La Roche Ltd
Q BioMed Inc.
*Disclaimer: Major Players sorted in no particular order
